Cegedim Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Cegedim de 97.3% y 5.7% por año respectivamente. Se prevé que el BPA crezca en un 102.2% al año. Se espera que la rentabilidad financiera sea de 7.2% en 3 años.

Información clave

56.1%

Tasa de crecimiento de los beneficios

55.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare Services	28.5%
Tasa de crecimiento de los ingresos	4.7%
Rentabilidad financiera futura	5.7%
Cobertura de analistas	Low
Última actualización	26 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 06

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

Nov 23

Previsiones de crecimiento de beneficios e ingresos

ENXTPA:CGM - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	703	20	31	N/A	1
12/31/2025	690	24	33	115	2
12/31/2024	652	21	28	101	2
12/31/2023	616	-7	22	98	N/A
9/30/2023	602	1	26	104	N/A
6/30/2023	589	10	30	111	N/A
3/31/2023	572	12	20	99	N/A
12/31/2022	555	14	10	86	N/A
9/30/2022	548	14	-7	64	N/A
6/30/2022	541	15	-25	42	N/A
3/31/2022	533	21	3	69	N/A
12/31/2021	525	26	31	96	N/A
9/30/2021	518	24	36	106	N/A
6/30/2021	512	22	41	116	N/A
3/31/2021	504	16	39	113	N/A
12/31/2020	497	11	36	110	N/A
9/30/2020	496	10	28	98	N/A
6/30/2020	494	8	21	85	N/A
3/31/2020	499	5	-6	57	N/A
12/31/2019	504	3	-33	29	N/A
9/30/2019	495	-1	-8	54	N/A
6/30/2019	486	-5	18	80	N/A
3/31/2019	477	0	41	102	N/A
12/31/2018	468	4	65	124	N/A
9/30/2018	464	8	41	100	N/A
6/30/2018	461	12	18	77	N/A
3/31/2018	459	10	16	75	N/A
12/31/2017	457	7	13	73	N/A
9/30/2017	452	-13	N/A	82	N/A
6/30/2017	438	-17	N/A	78	N/A
3/31/2017	435	-12	N/A	76	N/A
12/31/2016	429	-29	N/A	59	N/A
9/30/2016	438	13	N/A	52	N/A
6/30/2016	435	9	N/A	55	N/A
3/31/2016	432	1	N/A	9	N/A
12/31/2015	426	19	N/A	40	N/A
9/30/2015	364	0	N/A	89	N/A
6/30/2015	380	-6	N/A	62	N/A
3/31/2015	399	-4	N/A	130	N/A
12/31/2014	412	-8	N/A	127	N/A
9/30/2014	161	-26	N/A	132	N/A
6/30/2014	266	-11	N/A	163	N/A
3/31/2014	377	-5	N/A	143	N/A
12/31/2013	488	-14	N/A	150	N/A
9/30/2013	906	21	N/A	131	N/A
6/30/2013	904	4	N/A	130	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que CGM sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (1%).

Beneficios vs. Mercado: Se prevé que CGM sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que CGM sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (5.7% al año) de CGM crezcan más despacio que el mercado de French (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 5.7% al año) de CGM crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de CGM sea baja dentro de 3 años (7.2%).

Cegedim Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 7.9% to €19.37

Consensus EPS estimates fall by 18%

Cegedim Provides Revenue Guidance for the Full Year 2023

Cegedim SA Provides Revenue Guidance for the Full Year 2023

Consensus EPS estimates increase by 16%

Price target increased by 7.1% to €21.40

Recent updates

Price target decreased by 7.9% to €19.37

New major risk - Financial position

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: €0.051 (vs €0.68 in 3Q 2022)

Getting In Cheap On Cegedim SA (EPA:CGM) Might Be Difficult

Consensus EPS estimates fall by 18%

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

Cegedim Provides Revenue Guidance for the Full Year 2023

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

New minor risk - Earnings quality

Cegedim SA Provides Revenue Guidance for the Full Year 2023

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

Consensus EPS estimates increase by 16%

When Should You Buy Cegedim SA (EPA:CGM)?

Full year 2022 earnings: EPS exceeds analyst expectations

Price target increased by 7.1% to €21.40

Cegedim SA Provides Group Revenue Guidance for the Year 2023

Less than half of directors are independent

Cegedim SA to Report First Half, 2023 Results on Sep 20, 2023

Consensus forecasts updated

Cegedim SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Consensus forecasts updated

Cegedim Provides Revenue Guidance for 2022

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

First half 2022 earnings released: €0.40 loss per share (vs €0.47 profit in 1H 2021)

Cegedim SA (ENXTPA:CGM) acquired Merito, SAS.

Upcoming dividend of €0.50 per share

Price target decreased to €28.83

Less than half of directors are independent

Cegedim, Malakoff Humanis, Groupe VYV, PRO BTP in Talks for Acquisition of Equity Stake in Cegedim Santé

Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?

Investor sentiment improved over the past week

Cegedim SA Provides Revenue Guidance for the Year 2022

Cegedim SA to Report First Half, 2022 Results on Sep 20, 2022

Cegedim Provides Revenue Guidance for the Year 2021

First half 2021 earnings released: EPS €0.47 (vs €0.34 loss in 1H 2020)

Consensus forecasts updated

Is Cegedim SA (EPA:CGM) Trading At A 26% Discount?

Should You Think About Buying Cegedim SA (EPA:CGM) Now?

Consensus forecasts updated

Cegedim Provides Revenue Guidance for the Year 2021

Cegedim (EPA:CGM) Seems To Use Debt Quite Sensibly

Cegedim's (EPA:CGM) Shareholders Are Down 33% On Their Shares

Full year 2020 earnings released: EPS €0.78 (vs €0.20 in FY 2019)

Cegedim SA Provides Earnings Guidance for the Year 2021

Are Investors Undervaluing Cegedim SA (EPA:CGM) By 43%?

New 90-day low: €23.20

What Is Cegedim SA's (EPA:CGM) Share Price Doing?

Analysts update estimates

What Is The Ownership Structure Like For Cegedim SA (EPA:CGM)?

Cegedim SA (EPA:CGM) Delivered A Weaker ROE Than Its Industry

What Does Cegedim's (EPA:CGM) CEO Pay Reveal?

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Market bids up stock over the past week

New 90-day high: €27.50

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

New 90-day low: €22.30

Analysts lower EPS estimates to €0.88

Analysts lower EPS estimates to €1.21

New 90-day low: €23.50

New 90-day low - €26.40

Price target raised to €31.88

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento